Coxsackievirus A16 Epidemiology, diagnosis, and vaccine

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 2, 2014, Pages 360-367

  Mao, Qunying ^a   Wang, Yiping ^a   Yao, Xin ^a   Bian, Lianlian ^a   Wu, Xing ^a   Xu, Miao ^a   Liang, Zhenglun ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Animal model; Coxsackievirus A16 (CA16); Neutralizing antibody; Recombination; Vaccine

Indexed keywords

RNA VACCINE; VIRUS VACCINE;

ANTIBODY DETECTION; ARTICLE; COXSACKIE VIRUS A; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS A16; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EXPERIMENTAL MODEL; GENETIC RECOMBINATION; HAND FOOT AND MOUTH DISEASE; HUMAN; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NONHUMAN; REVERSE TRANSCRIPTION LOOP MEDIATED ISOTHERMAL AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGY; SEROLOGY; VACCINATION; CHINA; COINFECTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; ENTEROVIRUS; EPIDEMIOLOGY; HAND, FOOT AND MOUTH DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; VIROLOGY;

CHINA; CLINICAL LABORATORY TECHNIQUES; COINFECTION; DIAGNOSTIC TESTS, ROUTINE; DISEASE OUTBREAKS; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; HAND, FOOT AND MOUTH DISEASE; HUMANS; VIRAL VACCINES;

EID: 84896909452     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27087     Document Type: Article

References (74)

1. Sickles GM, Mutterer M, Feorino P, Plager H. Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc Soc Exp Biol Med 1955; 90:529-31; PMID:13273503; http://dx.doi. org/10.3181/00379727-90-22088
2. Ranganathan S, Singh S, Poh CL, Chow VT. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl Bioinformatics 2002; 1:43-52; PMID:15130856
3. Zou XN, Zhang XZ, Wang B, Qiu YT. Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4, 753 cases. Braz J Infect Dis 2012; 16:457-65; PMID:22964289; http://dx.doi.org/10.1016/j.bjid. 2012.08.001
4. Shi J, Huang X, Liu Q, Huang Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine 2013; 31:2130-6; PMID:23499595; http://dx.doi. org/10.1016/j.vaccine.2013.02.051
5. Goto K, Sanefuji M, Kusuhara K, Nishimura Y, Shimizu H, Kira R, Torisu H, Hara T. Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis 2009; 15:1689-91; PMID:19861078; http://dx.doi.org/10.3201/eid1510.090594
6. Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 2004; 23:275-6; PMID:15014311; http://dx.doi. org/10.1097/01.inf.0000115950.63906.78
7. Legay F, Lévêque N, Gacouin A, Tattevin P, Bouet J, Thomas R, Chomelt JJ. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg Infect Dis 2007; 13:1084-6; PMID:18214187; http://dx.doi. org/10.3201/eid1307.070295 (Pubitemid 47048085)
8. Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J 1958; 79:615-21; PMID:13585281
9. Ferson MJ, Bell SM. Outbreak of Coxsackievirus A16 hand, foot, and mouth disease in a child daycare center. Am J Public Health 1991; 81:1675- 6; PMID:1746672; http://dx.doi.org/10.2105/ AJPH.81.12.1675
10. Bendig JW, Fleming DM. Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun Dis Rep CDR Rev 1996; 6:R81-6; PMID:8664928
11. Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol 2008; 49:103-12; PMID:19054914; http://dx.doi.org/10.1016/S1875-9572(08)60023-6
12. Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009; 38:106-12; PMID:19271036
13. Tu PV, Thao NT, Perera D, Huu TK, Tien NT, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis 2007; 13:1733- 41; PMID:18217559; http://dx.doi.org/10.3201/ eid1311.070632 (Pubitemid 350126202)
14. Kar BR, Dwibedi B, Kar SK. An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha. Indian Pediatr 2013; 50:139-42; PMID:22728634; http://dx.doi.org/10.1007/s13312-013-0033-0
15. Zhu J, Luo Z, Wang J, Xu Z, Chen H, Fan D, Gao N, Ping G, Zhou Z, Zhang Y, et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One 2013; 8:e56318; PMID:23418551; http://dx.doi.org/10. 1371/journal. pone.0056318
16. Clinical Trials [Internet]. A protected study of inactivated EV71 vaccine (human diploid cell, KMB-17) in Chinese infants and children. 2013. Available from: http://clinicaltrials.gov/show/NCT01569581
17. Positive topline results from Phase III trial of Enterovirus 71 vaccine (Sinovac Biotech) against Hand, Foot and Mouth Disease. 2013. http://www. sinovac.com/?optionid=754&auto-id=715
18. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et al. Efficacy, safety, and immunology of an inactivated alumadjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebocontrolled, phase 3 trial. Lancet 2013; 381:2024- 32; PMID:23726161; http://dx.doi.org/10.1016/ S0140-6736(13)61049-1
19. Wright HT Jr., Landing BH, Lennette EH, McALLISTER RM. Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med 1963; 268:1041-4; PMID:14001956; http://dx.doi.org/10.1056/NEJM196305092681904
20. WS. Y. Clinical characteristic analysis of 104 cases of children severe hand, foot and mouth disease. Chongqing Med 2011; 40:6
21. Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB, Xiong XY. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J 2012; 9:8; PMID:22230340; http://dx.doi.org/10.1186/1743-422X-9-8
22. Zhao K, Han X, Wang G, Hu W, Zhang W, Yu XF. Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg Infect Dis 2011; 17:1537-40; PMID:21801645
23. Zhang HMLC, Li CR, Liu YJ, Liu WL, Fu D, Xu LM, Xie JJ, Tan Y, Wang H, Chen XC, et al. [To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009; 23:334-6; PMID:20387478
24. Pan H, Zhu YF, Qi X, Zhang YJ, Li L, Deng F, Wu B, Wang SJ, Zhu FC, Wang H. [Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China]. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30:339-43; PMID:19731523
25. Yip CC, Lau SK, Zhou B, Zhang MX, Tsoi HW, Chan KH, Chen XC, Woo PC, Yuen KY. Emergence of enterovirus 71 "double-recombinant"strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol 2010; 155:1413-24; PMID:20549263; http://dx.doi.org/10.1007/s00705-010- 0722-0
26. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010; 7:94; PMID:20459851; http://dx.doi.org/10.1186/1743-422X-7-94
27. Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 2012; 30:6642-8; PMID:22959985; http://dx.doi. org/10.1016/j.vaccine.2012.08.071
28. Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 2013; 31:2215-21; PMID:23499596; http://dx.doi.org/10.1016/j.vaccine.2013.03.007
29. http://www.cdc.gov.tw.
30. Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J 2010; 7:300; PMID:21050463; http://dx.doi.org/10.1186/1743-422X-7-300
31. http://www.chinacdc.cn/tjsj/fdcrbbg/.
32. Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 2009; 62:254-9; PMID:19628900
33. Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 2005; 43:3835-9; PMID:16081920; http://dx.doi.org/10.1128/JCM.43.8.3835-3839.2005 (Pubitemid 41129670)
34. Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 2003; 9:291- 3; PMID:12643822; http://dx.doi.org/10.3201/ eid0903.020285
35. Podin Y, Gias EL, Ong F, Leong YW, Yee SF, Yusof MA, Perera D, Teo B, Wee TY, Yao SC, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 2006; 6:180; PMID:16827926; http://dx.doi.org/10.1186/1471-2458-6-180
36. Huang W, et al. Genetic analysis and etiology study of hand-foot mouth disease in surveillance hospitals of Hunan province during the period of 2008-2010. Pract Prev Med 2011; 18:779-84
37. Jia L, Zhao CS, Zhang L, Li S, Zhang DT, Liu BW, Wang QY, Li XY. [Comparisons of epidemiological and clinical characteristics in children with handfoot- mouth disease caused by Enterovirus 71 and Coxackievirus A16]. Zhongguo Dang Dai Er Ke Za Zhi 2011; 13:635-7; PMID:21849112
38. Ye RXZY, Pan KN, Tong YX. Significance of enterovirus 71 and coxsackievirus 16 pathogens detection in preventing epidemics of hand, foot and mouth disease. Chin J Nosocomiol 2011; 21:1295-6
39. Zhang YJBJ, Huang XL. Clinical analysis of 54 cases of hand, foot and mouth disease with central nervous system damage. Chin J CritCare Med 2010; 30:1090-2
40. Zhang W, et al. Severe hand, foot, and mouth disease caused by mixed infection of enterovirus 71 and coxsackie A16: report of 6 cases. Chin Gen Practice 2011; 14:3341-6
41. Zhang Y, Wang D, Yan D, Zhu S, Liu J, Wang H, Zhao S, Yu D, Nan L, An J, et al. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol 2010; 48:619-22; PMID:20018819; http://dx.doi. org/10.1128/JCM.02338- 09
42. Zong W, He Y, Yu S, Yang H, Xian H, Liao Y, Hu G. Molecular phylogeny of Coxsackievirus A16 in Shenzhen, China, from 2005 to 2009. J Clin Microbiol 2011; 49:1659-61; PMID:21325543; http://dx.doi.org/10.1128/JCM.00010-11
43. Zhou F, Kong F, Wang B, McPhie K, Gilbert GL, Dwyer DE. Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5? untranslated region and VP1 region. J Med Microbiol 2011; 60:349-58; PMID:21148280; http://dx.doi. org/10.1099/jmm.0.025056-0
44. Perera D, Yusof MA, Podin Y, Ooi MH, Thao NT, Wong KK, Zaki A, Chua KB, Malik YA, Tu PV, et al. Molecular phylogeny of modern coxsackievirus A16. Arch Virol 2007; 152:1201-8; PMID:17308978; http://dx.doi.org/10.1007/s00705-006- 0934-5 (Pubitemid 46800712)
45. Brown BA, Oberste MS, Alexander JP Jr., Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999; 73:9969-75; PMID:10559310
46. Phuektes P, Chua BH, Sanders S, Bek EJ, Kok CC, McMinn PC. Mapping genetic determinants of the cell-culture growth phenotype of enterovirus 71. J Gen Virol 2011; 92:1380-90; PMID:21346025; http://dx.doi.org/10.1099/vir.0. 029371-0
47. Yang E, Zhao H, Zhang Y, Liu J, Liao Y, Wang L, Cui P, Yang L, Liu L, Dong C, et al. A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B). Science China. Life Sci 2012; 55:336-42; http://dx.doi.org/10.1007/ s11427-012-4313-z
48. Ni H, Yi B, Yin J, Fang T, He T, Du Y, Wang J, Zhang H, Xie L, Ding Y, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011. J Clin Virol 2012; 54:342-8; PMID:22652041; http://dx.doi. org/10.1016/j.jcv.2012.04.021
49. Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, Song XF, Yao X, Li JX, Ji H, et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 2012; 7:e37206; PMID:22662137; http://dx.doi. org/10.1371/journal.pone. 0037206
50. Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 2010; 199:45-51; PMID:19941005; http://dx.doi. org/10.1007/s00430-009- 0133-6
51. Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol 2009; 154:1139-42; PMID:19506798; http://dx.doi.org/10.1007/ s00705-009-0413-x
52. Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002; 109:e88; PMID:12042582; http://dx.doi. org/10.1542/peds.109.6.e88
53. Kung SH, Wang SF, Huang CW, Hsu CC, Liu HF, Yang JY. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect 2007; 13:782-7; PMID:17488328; http://dx.doi.org/10.1111/j. 1469-0691.2007.01745.x
54. Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. J Virol Methods 2013; 187:362-7; PMID:23178532; http://dx.doi.org/10.1016/j.jviromet.2012.11.014
55. Yu N, Guo M, He SJ, Pan YX, Chen XX, Ding XX, Hao W, Wang YD, Ge SX, Xia NS, et al. Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease. Virol J 2012; 9:12; PMID:22234169; http://dx.doi. org/10.1186/1743-422X-9-12
56. Zhu D, Zhao XY, Yao Y, Dai FF, He H, Li RQ, Jin RH, Liang LC, Li N. A new factor influencing pathogen detection by molecular assay in children with both mild and severe hand, foot, and mouth disease. Diagn Microbiol Infect Dis 2013; 76:162- 7; PMID:23535205; http://dx.doi.org/10.1016/j. diagmicrobio.2013.02.011
57. Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 1995; 39:195-205; PMID:8837884; http://dx.doi.org/10.1016/0168-1702(95)00087-9 (Pubitemid 26054785)
58. Xu F, He D, He S, Wu B, Guan L, Niu J, Li L, Li C, Weng Z, Yan Q, et al. Development of an IgMcapture ELISA for Coxsackievirus A16 infection. J Virol Methods 2011; 171:107-10; PMID:20970457; http://dx.doi.org/10.1016/j.jviromet. 2010.10.009
59. Singh S, Chow VT, Phoon MC, Chan KP, Poh CL. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription- PCR with universal enterovirus and EV71- specific primers. J Clin Microbiol 2002; 40:2823-7; PMID:12149336; http://dx.doi.org/10.1128/ JCM.40.8.2823-2827.2002 (Pubitemid 35284947)
60. Chen HMJ, Ma XM. Analysis of etiology detection result of HFMD cases in Ningxia in2008. Ningxia Med J 2009; 33:515-6
61. Jiang B, Zhang J, You X, Dong C, Cheng X, Dai X, Meng J. Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. J Med Virol 2012; 84:1803-8; PMID:22997084; http://dx.doi. org/10.1002/jmv.23391
62. Yang F, Zhang T, Hu Y, Wang X, Du J, Li Y, Sun S, Sun X, Li Z, Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 2011; 8:508; PMID:22054534; http://dx.doi.org/10.1186/1743- 422X-8-508
63. Tan EL, Chow VT, Quak SH, Yeo WC, Poh CL. Development of multiplex real-time hybridization probe reverse transcriptase polymerase chain reaction for specific detection and differentiation of Enterovirus 71 and Coxsackievirus A16. Diagn Microbiol Infect Dis 2008; 61:294-301; PMID:18394844; http://dx.doi.org/10.1016/j. diagmicrobio.2008.02.009 (Pubitemid 351847799)
64. Chen TC, Chen GW, Hsiung CA, Yang JY, Shih SR, Lai YK, Juang JL. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol 2006; 44:2212- 9; PMID:16757623; http://dx.doi.org/10.1128/ JCM.02393-05 (Pubitemid 43902178)
65. Song L, Sun S, Li B, Pan Y, Li W, Zhang K, Li J. External quality assessment for enterovirus 71 and coxsackievirus A16 detection by reverse transcription- PCR using armored RNA as a virus surrogate. J Clin Microbiol 2011; 49:3591-5; PMID:21865426; http://dx.doi.org/10.1128/JCM.00686-11
66. Wang X, Zhu JP, Zhang Q, Xu ZG, Zhang F, Zhao ZH, Zheng WZ, Zheng LS. Detection of enterovirus 71 using reverse transcription loop-mediated isothermal amplification (RT-LAMP). J Virol Methods 2012; 179:330-4; PMID:22155579; http://dx.doi. org/10.1016/j.jviromet.2011.11.019
67. Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 2012; 86:11967-76; PMID:22951825; http://dx.doi. org/10.1128/JVI.00902-12
68. Liu F, Liu Q, Cai Y, Leng Q, Huang Z. Construction and characterization of an infectious clone of coxsackievirus A16. Virol J 2011; 8:534; PMID:22165961; http://dx.doi.org/10.1186/1743-422X-8-534
69. Liu Q, Ku Z, Cai Y, Sun B, Leng Q, Huang Z. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods 2011; 173:115-20; PMID:21295614; http://dx.doi. org/10.1016/j.jviromet.2011.01.016
70. Puenpa J, Theamboonlers A, Korkong S, Linsuwanon P, Thongmee C, Chatproedprai S, Poovorawan Y. Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011. Arch Virol 2011; 156:2007-13; PMID:21898187; http://dx.doi. org/10.1007/s00705-011-1098-5
71. Qiaoyun F, Xiongfei J, Lihuan L, Angao X. Epidemiology and etiological characteristics of hand, foot and mouth disease in Huizhou City between 2008 and 2011. Arch Virol 2013; 158:895- 9; PMID:23229012; http://dx.doi.org/10.1007/ s00705-012-1566-6
72. Zhou X, Fan G, Xia W, He F, Hu M, Ni X, Zhang Y, Chen H. Molecular epidemiology of human enterovirus 71 strains in the Nanchang region of China in 2011. Jpn J Infect Dis 2013; 66:149- 50; PMID:23514913; http://dx.doi.org/10. 7883/ yoken.66.149
73. Urquhart GE. A survey of coxsackie A16 virus antibodies in human sera. J Hyg (Lond) 1984; 93:205- 12; PMID:6094661; http://dx.doi.org/10.1017/ S002217240006472X (Pubitemid 15207948)
74. Lin Y, Wen K, Pan Y, Wang Y, Che X, Wang B. Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16. J Immunoassay Immunochem 2011; 32:233-43; PMID:21574094; http://dx.doi.org/10.1080/153218 19.2011.559297